Aura Biosciences D
D
AURA
6.18000
USD
-0.10
(-1.59%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
48,121
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
640,895,720
العنوان: Aura Biosciences
القطاع: الرعاية الصحية
الصناعة: Biotechnology
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.